Methyl 2-(3-(4-butoxybenzoyl)-2-(2-fluorophenyl)-4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylthiazole-5-carboxylate

Catalog No. :
ACRRQP813
CAS No. :
617695-44-0
Molecular Formula :
C27H25FN2O6S
Molecular Weight :
524.57

IUPAC Name:methyl 2-(3-(4-butoxybenzoyl)-2-(2-fluorophenyl)-4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylthiazole-5-carboxylate

Methyl 2-(3-(4-butoxybenzoyl)-2-(2-fluorophenyl)-4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylthiazole-5-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-(3-(4-butoxybenzoyl)-2-(2-fluorophenyl)-4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylthiazole-5-carboxylate
IUPAC Namemethyl 2-(3-(4-butoxybenzoyl)-2-(2-fluorophenyl)-4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylthiazole-5-carboxylate
Molecular FormulaC27H25FN2O6S
Molecular Weight524.57
SMILESCCCCOC1=CC=C(C(=O)C2=C(O)C(=O)N(C3=NC(C)=C(C(=O)OC)S3)C2C2=CC=CC=C2F)C=C1
InChI KeyFNUMHQAYRFWMKB-UHFFFAOYSA-N
SynonymSALOR-INT L439452-1EA;METHYL 2-[3-(4-BUTOXYBENZOYL)-2-(2-FLUOROPHENYL)-4-HYDROXY-5-OXO-2,5-DIHYDRO-1H-PYRROL-1-YL]-4-METHYL-1,3-THIAZOLE-5-CARBOXYLATE
CAS No.617695-44-0

Synthetic Route by SureRoute

1. ACRRQP813 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRRQP813 route product structure diagram
    ACRRQP813617695-44-0
Inquiry

2. ACRRQP813 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Then
  5. ACRRQP813 route product structure diagram
    ACRRQP813617695-44-0
Inquiry

Comments (0)